Discover the newest products from the PerkinElmer reagent portfolio launch
PerkinElmer’s teams work diligently every day to develop new products in order to provide additional therapeutic targets and contribute to major advances in understanding human biology. After several months of research and scientific expertise, we are pleased to announce the October launch of new products!
New products using the HTRF® technology
The Phospho assays portfolio is enriched with 8 new kits covering oncology area and targeted protein degradation assays.
Using the AlphaLISA® technology
Using the AlphaLISA® SureFire® Ultra™ technology
Cellular Phospho-Proteins Assays portfolio is enriched with 24 new assays:
- AKT 1/2/3 Phospho-T450 Kit
- ALK Phospho-Y1604 Kit
- CaMKII Phospho-T286 Kit
- CaMKII Total Kit
- CD3 Zeta Phospho-Y142 Kit
- CD3 Zeta Phospho-Y83 Kit
- CD3 Zeta Total Kit
- c-Myb Phospho-S11 Kit
- c-Myb Total Kit
- ERα Phospho-S118 Kit
- ERα Phospho-S167 Kit
- ERα Total Kit
- IkBα Phospho-S32/36 Kit
- IkBα Total Kit
- IKKβ Phospho-S177/181 Kit
- IKKβ Total Kit
- PDHA1 Phospho-S293 Kit
- PDHA1 Total Kit
- SQSTM1 p62 Phospho-S403 Kit
- SQSTM1 p62 Total Kit
- TDP43 Phospho-S409/410 Kit
- TDP43 Total Kit
- AKT 1/2/3 Phospho-T308 + AKT 1/2/3, Total Kit
- AKT 1/2/3 Phospho-T450 + AKT 1/2/3, Total Kit
- ALK Phospho-Y1604 + ALK, Total Kit
- Ret Phospho-panY + Ret, Total Kit
- SLP-76 Phospho-S376 + SLP-76, Total Kit
New products flyer
Get our up-to-date listing of new products and find the related sales part numbers
